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GEORGE A. BELLER, MD, FACC, JACK W. FLEMING, MD, FACC, JAMES L. RITCHIE, MD, FACC 
I. Training in Nuclear Cardiology 
Nuclear cardiologic methods (Table I) frequently provide 
important diagnostic and prognostic information with which 
all modem cardiologists should be conversant. Training for 
cardiology fellows should be divided into three levels. 
A. General training (2 months) for all cardiology fellows 
is designed to make the fellow conversant with the field 
of nuclear cardiology (level 1). 
B. Specialized training (4 months) for individuals who wish 
to have special expertise in clinical nuclear cardiology 
and responsibility for all clinical nuclear cardiologic ac-
tivity (level 2). 
C. Advanced training (1 year) for trainees who wish to 
pursue an academic direction in nuclear cardiology in-
cluding patient care, teaching and research (level 3). 
Training should include the study of the indications for 
specific nuclear cardiology tests and proper clinical appli-
cation of the diagnostic information derived from the ap-
propriate test. An understanding of how to interpret the 
nuclear cardiologic test results using other available clinical 
information is required. It is essential that the training con-
vey an adequate understanding of these clinical correlations. 
Ideally, a cardiologist should be designated as the person 
responsible for directing the nuclear cardiology training pro-
gram. Certain components of the training experience may 
be provided in collaboration with individuals from nuclear 
medicine/nuclear radiology. The preceptor should ensure 
that a log book or other specific records document cases 
and didactic training hours in which the fellow has partic-
ipated. In the case of the advanced trainee, specialized train-
ing and research can be derived as a part of an established 
program either in cardiology or in a Division of Nuclear 
MedicinelDepartment of Radiology. 
A. General Training-Levell (2 months' minimum) 
The fundamentals of nuclear cardiology technology and 
practice require at least 2 months of full-time training or 
the equivalent amount of time distributed throughout the 
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fellowship period. A considerable portion of this time must 
be devoted to clinical applications. Adequate technologic 
expertise for fellows not intending to practice nuclear car-
diology can be learned as a part of this 2 month clinical 
experience. 
1. Background. To have an adequate understanding of 
the clinical applications of nuclear cardiology and to perform 
the test safely, the physician trainee must acquire proficiency 
in the following areas: 
a. Coronary angiography and dynamics 
b. Cardiac hemodynamics 
c. Cardiac pathophysiology 
d. Rest and exercise electrocardiography 
e. Exercise physiology 
f. Pharmacology of standard cardiovascular drugs 
g. Cardiopulmonary resuscitation and treatment of other 
cardiac emergencies 
h. Applications of pharmacologic agents such as dipyrid-
amole 
1. Applications of echocardiography 
j. Acute coronary care and cardiopulmonary resuscitation 
2. Didactic program. a. Interpretation of radionuclide 
studies. During their 2 month rotation, fellows should ac-
tively participate in daily radionuclide study interpretation 
(classification 1, Table I) under the direction of a qualified 
individual in nuclear cardiology (minimum of 80 hours). 
For all studies in which angiographic or hemodynamic data, 
or both, are available, such information should be correlated 
with the radionuclide studies. Studies should include one 
or more of the following: 
1) Myocardial (perfusion) imaging with exercise and re-
distribution or rest studies, or both, using qualitative and 
quantitative analysis; 
2) Radionuclide cineangiography using the equilibrium or 
"first pass" approach, or both; and 
3) Myocardial infarct imaging with pyrophosphate and, in 
addition (where available), experience with class 2 (Ta-
ble I) methods, such as myocarditis detection with gal-
lium-67 citrate, clot detection with radiolabeled fibrin-
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Table I. ClassificatIOn of Nuclear Cardiologic and 
Imagmg Procedure, 
Standard nuclear cardIologIC procedure, 
a. MyocardIal (perfu'lon) Imaging 
b. Gated equIlIbrIum or fiN pa" radlOnuchde cIneangIography. 
or both 
c. MyocardIal InfarctIOn imaging 
d. Shunt qudles 
2 Le,s common nuclear cardiologIC procedure, 
a. Galhum-67 5tudies for detectIon of myocardItis 
b Radlolabeled blood products (for example. fibrInogen or platelets) 
c. Intracoronary radiOIsotope administratIon (for example, xenon-133 
or labeled microspheres) 
3. Advanced nuclear cardiology procedures 
a Single photon emIssion computed tomography (SPECT) 
b. POSItron emISSIon tomography (PET) 
4. Related general nuclear medIcine procedures 
a. Lung perfusion scannIng 
b Lung ventIlation scanning 
5. Advanced nonradlOnuchde cardiova,cular ImagIng procedures 
a. Nuclear magnetic resonance imaging procedures 
b. Hlgh-,peed X-ray computed tomography 
ogen and platelets and shunt evaluation and quantification 
by first pass analysis. 
Ideally, experience in all of these aspects of nuclear car-
diology is recommended. Nevertheless, in institutions that 
emphasize certain procedures, adequate background for 
general fellowship training in nuclear cardiology can be 
satisfied with less diversified training. 
h. Lecture and reading in nuclear cardiology. The sec-
ond component of the didactic program should consist of 
lectures on the basic aspects of nuclear cardiology and par-
allel reading material. The lectures and reading should pro-
vide the fellow with an outline of the realistic applications 
of nuclear cardiology and should distinguish between re-
search and accepted clinical applications. Specificity, sen-
sitivity, diagnostic accuracy, utility, costs, indications and 
pitfalls must be emphasized for each patient subset. Such 
information could be effectively transmitted within a weekly 
noninvasive conference or catheterization conference during 
which the radionuclide imaging data are presented. 
c. Appreciation of radiation safety. The third component 
of the didactic program should provide the fellow with an 
appreciation of radiation safety as it relates to administration 
of radiopharmaceuticals. The cardiology fellow should ar-
rive in the nuclear cardiology facility with an appreciation 
for radiation safety based on experience in the catheteriza-
tion laboratory. In addition, the radiation safety officer (or 
other appropraite individual) at the training institution should 
provide the fellows with a series of lectures or laboratories, 
or both, dealing with basic radiation physics, radionuclide 
safety and Nuclear Regulatory Commission requirements. 
3. Hands-on experience. Fellows should perform entire 
nuclear cardiology studies at the side of the technologist or 
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other qualified personnel. They should observe and then 
participate under qualified supervi~ion in the following pro-
cedures: preparation and calibration of the radiopharma-
ceutical dosage: admillistration of the radiopharmaceutical: 
treadmill. bicycle and supine exercise stress testing, alone 
or in combination; application of the gating device operation 
of the gamma camera (with quality contro\); operation of 
the imaging computer system during acquisition; processing 
of images after acquisition and appropraite display of im-
ages. This should include adequate experience in exercise 
thallium myocardial imaging, radionuclide cineangiocar-
diography (rest or exercise, or both; equilibrium or first pass, 
or both) and miscellaneous procedures. 
Summary of Levell,' General Training 
A 2 month period of training should be provided during 
which lectures, hands-on application and interpretations of 
nuclear cardiology methods are offered. Often, such ex-
perience can be acquired in parallel with experience in the 
exercise or echocardiography laboratory, or both. Although 
not essential, the fellow would likely derive optimal ex-
perience by participating in a continuous 2 month program 
with clinical interpretations and hands-on technical appli-
cations. 
B. Specialized Training-Level 2 (4 months) 
Individuals who wish to practice in the specialty of nu-
clear cardiology should be required to have at least 2 months 
of training in addition to that recommended for level I, 
"General Training." This additional training should be ded-
icated to enhancing clinical skills and qualifying for nuclear 
regulatory commission licensure. Again, class I (Table 1) 
procedure should be emphasized with exposure as available 
to class 2 and 3 procedures. 
1. Didactic program (minimum of 200 hours). In ad-
dition to the basic program for level I training (80 hours), 
120 hours of additional radiation safety training should be 
provided to satisfy Nuclear Regulatory Commission licen-
sure requirements. This program might be scheduled over 
a 12 to 24 month period concurrent with other fellowship 
assignments. The fellow should participate in interpretation 
of all nuclear cardiology imaging data for the 4 month train-
ing interval. During the course of this 4 month training 
period, it is imperative that the fellow have experience in 
correlating catheterization/angiographic data with radio-
nuclide-derived data in a minimum of 30 patients. It is 
recommended that a teaching conference in which the fellow 
presents the clinical material and scintigraphic results is an 
appropriate forum for such an experience. The minutes or 
written logbook should be kept: cases and diagnoses should 
also be listed to provide documentation. 
2. Hands-on experience (minimum of 50 patients). 
Fellows interested in specializing in clinical nuclear car-
diology should have additional hands-on experience with 
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patient studies. Additional intensive experience should be 
acquired in a minimum of 50 patients: optimally 25 patients 
for myocardial (perfusion) imaging and 25 patients for radio-
nuclide angiography (total 50 patients). In institutions where 
myocardial infarct imaging studies are emphasized. expe-
rience in 10 patients with this approach can be substituted 
to acquire the total experience of 50 patients. Such super-
vised experience should include patient workups. radiophar-
maceutical preparation (including experience with relevant 
radionuclide generators), administration of the dosage. per-
formance of the study (rest. exercise or dipyridamole), cal-
ibration and set-up of the gamma camera. setup of the im-
aging computer and processing the data for display after 
acquisition. 
3. Additional experience. In addition, the training pro-
gram must provide experience ill computer methods for anal-
ysis of thallium imaging studies. and ejection fraction and 
regional wall motion measurements from radionuclide an-
giography studies. 
Summary of Level 2: Specialized Training (4 months) 
A 4 month training period will provide a means for the 
trainee to learn the essentials of the clinical aspects of nu-
clear cardiology and to acquire adequate experience to main-
tain safety in the medical use of isotopes. The training 
should include a didactic component of at least 200 hours* 
and a hands-on component with total experience in at least 
50 patient studies. These should emphasize class I studies. 
but should also provide exposure to class 2 and. if available. 
class 3 studies. Both classroom and clinical training should 
include the following: 
radiopharmaceutical experience 
. radiation safety experience 
equipment quality assurance procedures 
Nuclear Regulatory Commission safety and record-keep-
ing requirements 
Evaluation. Both the individual responsible for the nu-
clear cardiology training program and the program director 
should also be responsible for evaluating the competence 
of the trainee in nuclear cardiology at the completion of the 
program. This can be accomplished by observing the per-
formance of the fellow during the daily reading se~sions or 
by a formal testing procedure. or both. 
C. Advanced Training-Level 3 (minimum of 
1 year) 
For individuals who wish to pursue an academiC career 
in nuclear cardiology. an extended program is encouraged. 
In addition to the recommended program for level 2, this 
program should include active participation in ongoing lab-
oratory and clinical research with individual responsibility 
'Thl, may be given over a 12 to 36 month penod 
TASK FORCE V 
I\L'CU:AR CARDIOLOGY AND MAGNETIC RESONANCE 
1211 
for a ~cgment of that research. In parallel with participation 
in a research program. the trainee should participate in clin-
ical imaging activities for the total training period of 12 or 
more months. Hands-on experience should be similar to or 
greater than that required for the clinical practitioner. The 
fellow should be trained in most of the following areas: 
I. Qualitative interpretation of standard nuclear cardiology 
studies including myocardial (perfusion) imaging. gated 
equilibrium studies. first pass and infarct imaging stud-
Ies. 
2. Quantitative thallium or alternative flow or metabolic 
markers. 
3. Quantitative radionuclide angiographic analyses includ-
ing measurement of global and regional ventricular func-
tion. ventricular and pulmonary blood volumes. and so 
forth. 
4. Shunt studies. 
5. Qualitative interpretation of lung scans (ventilation and 
perfusion). 
6. Single photon emission computed tomography (SPECT) 
studies. * 
7. GalJium-67 citrate. labeled platelets. antibody to cardiac 
myosin and other potentially clinically relevant studies. 
8. Positron emission tomography (PET) studies. * 
9. Other forms of cardiac imaging such as nuclear magnetic 
resonance (NMR) imaging or fast X-ray computed to-
mography. * 
Summary of Level 3: Advanced Training (minimum of 
1 year) 
For individuals who wish to pursue an academic focus 
in nuclear cardiology. a minimum of I year of training is 
recommended. This should include the components of the 
level 2 programs. but also should contain classes 3 to 5 
experience (Table I). Concurrent involvement in research 
is essential. The same method of evaluation of proficiency 
as indicated in level 2 should be applied. 
II. Training in Nuclear Magnetic Resonance 
Nuclear magnetic resonance imaging and spectroscopy 
are unique technologies that are now being developed for 
cardiac application. Imaging of the cardiovascular system 
with (proton) nuclear magnetic resonance demonstrates con-
siderable promise as a diagnostic tool for a multitude of 
potentially useful applications. As the cardiologist is the 
physician most knowledgeable in areas related to anatomy. 
angiography. pathophysiology. biochemistry and general 
clinical expertise. the interpretation of such studies is best 
accomplished by the cardiologist for maximal patient ben-
efit. Accordingly. even in this early period of development 
of nuclear magnetic resonance as a cardiovascular diagnostic 
tool. it would be highly desirable that the cardiology trainee 
*If availahle 
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be involved in the cardiovascular applications of nuclear 
magnetic resonance where available and feasible. This ex-
posure should consist of didactic and practical experience. 
Didactic training (at least 20 hours). A series of di-
dactic training sessions discussing the technology, its lim-
itations and values, its risks and benefits and its clinical 
indications and potentials should be provided. Ideally, the 
trainee should be provided with an understanding of the 
principles of both nuclear magnetic resonance spectroscopy 
and imaging. The lecture series should include a review of 
relevant cardiac biochemistry. 
Practical experience (50 patients). The trainee should 
participate in interpretation of cardiovascular studies in-
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cluding gated proton images to evaluate morphology, ven-
tricular function and size and relaxation property (T I and 
T 2) assessment to detect myocardial infarction. The trainee 
should be encouraged to participate in imaging studies and 
postacquisition data handling. He or she should be conver-
sant with nuclear magnetic resonance methods employed 
for acquisition to derive an understanding of the significance 
of differences in image intensity. The relation between the 
radio frequency pulse sequence and resultant image ap-
pearance on T I, T 2, proton concentration and blood or organ 
motion should be stressed. After completion of the above 
program, the trainee should be competent in the interpre-
tation of nuclear magnetic resonance imaging studies. 
